21-Gene Assay

[PMID: 26412349] [New England Journal of Medicine]

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

TAILORx trial on Oncotype DX. “For those seeking confirmation that this assay can identify a cohort of patients who should be spared chemotherapy, this result is both reassuring and frustrating.”

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s